Form 4: GRAIL Director Gregory Summe Awarded Over 6,000 Deferred Stock Units

GRAIL, Inc. Director Gregory L. Summe was granted 6,082 deferred stock units (DSUs) on May 29, 2025, as part of the company's 2024 Equity Incentive Plan, increasing his beneficial ownership to 37,544 shares.

Summary

• Reporting Person: Gregory L. Summe, a Director of GRAIL, Inc.
• Transaction Date: May 29, 2025.
• Transaction Type: Acquisition of 6,082 shares of Common Stock in the form of Deferred Stock Units (DSUs).
• Award Details: The DSUs were granted under the company's 2024 Equity Incentive Plan, in lieu of restricted stock units.
• Vesting Schedule: The DSUs will vest in full on the earlier of May 29, 2026, or the date of the next annual meeting of stockholders, contingent on continued service.
• Post-Transaction Ownership: Following this transaction, Mr. Summe beneficially owns 37,544 shares of GRAIL, Inc. common stock.
• Implied Price: The transaction was recorded at an implied price of $41.1 per share.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as the filing indicates a routine equity compensation award to a director, which aligns management's interests with shareholders and is a standard practice for incentivizing long-term commitment and performance.

Positives

• The award of 6,082 deferred stock units (DSUs) to Director Gregory L. Summe aligns his interests with those of shareholders, as the value of the DSUs is tied to the company's stock performance.
• The grant is part of the company's 2024 Equity Incentive Plan, indicating ongoing efforts to incentivize and retain key personnel.

Negatives

• No direct negatives are apparent from this standard equity compensation filing.

Future Outlook

The 6,082 deferred stock units are scheduled to vest in full on the earlier of May 29, 2026, or the date of the next annual meeting of the Company's stockholders, contingent upon Gregory L. Summe's continued service.

Industry Context

The grant of deferred stock units to a director is a common practice in the biotechnology and healthcare industries, serving as a key component of executive and director compensation packages designed to align leadership incentives with long-term shareholder value creation. This type of equity award is frequently used by companies like GRAIL, Inc. to attract and retain experienced board members.

Comparison to Industry Standards

• While specific comparable companies or projects are not detailed in this filing, the practice of granting equity awards like DSUs to directors is a standard compensation mechanism across the biotech and broader public company landscape. Such awards are typically benchmarked against peer groups to ensure competitive compensation and alignment with industry norms for corporate governance and incentive structures.

Related Party Transactions

• The award of 6,082 deferred stock units to Gregory L. Summe, a Director of GRAIL, Inc., constitutes a related party transaction as it involves compensation provided to a member of the company's board.

Stakeholder Impact

• Shareholders: The equity award to a director aims to align management's long-term interests with shareholder value creation.
• Employees: The award is part of the company's 2024 Equity Incentive Plan, which generally benefits employees through similar incentive structures, fostering retention and performance.

Next Steps

• The deferred stock units are expected to vest on the earlier of May 29, 2026, or the date of the next annual meeting of stockholders, subject to continued service.

Key Dates

Keywords

GRAIL Inc., GRAL, SEC Form 4, Insider Transaction, Director Compensation, Equity Incentive Plan, Deferred Stock Units, DSUs, Stock Award, Executive Compensation